Koninklijke DSM N.V Key Executives

This section highlights Koninklijke DSM N.V's key executives, including their titles and compensation details.

Unlock Executive Information

Upgrade to access executive details

Upgrade Now

Find Contacts at Koninklijke DSM N.V

(Showing 0 of )

Unlock Team Information

Upgrade to access team member details

Upgrade Now

Koninklijke DSM N.V Earnings

This section highlights Koninklijke DSM N.V's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.

Next Earnings Date

Date:
Time:
Est. EPS: $-
Status: Unconfirmed

Last Earnings Results

Date: August 02, 2023
EPS: $-
Est. EPS: $0.95
Revenue: $-

Earnings Call Transcripts

Transcript Quarter Year Date Estimated EPS Actual EPS
Read Transcript Q3 2024 2024-11-01 N/A N/A
Read Transcript Q2 2024 2024-08-03 N/A N/A
Read Transcript Q1 2024 2024-05-04 N/A N/A

Koninklijke DSM N.V. (DSM.AS)

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.

Basic Materials Chemicals - Specialty

$114.05

Stock Price

$763.73M

Market Cap

-

Employees

Heerlen, None

Location

Financial Statements

Access annual & quarterly financial statements for Koninklijke DSM N.V, including income statements, balance sheets, and cash flow statements..

Annual Income Statement

Breakdown December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019 December 31, 2018
Revenue $8.39B $9.20B $8.11B $9.01B $9.27B
Cost of Revenue $5.70B $6.04B $5.33B $5.96B $5.86B
Gross Profit $2.69B $3.16B $2.78B $3.05B $3.40B
Gross Profit Ratio 32.06% 34.40% 34.25% 33.88% 36.74%
Research and Development Expenses $295.00M $323.00M $398.00M $349.00M $348.00M
General and Administrative Expenses $534.00M $517.00M $469.00M $525.00M $530.00M
Selling and Marketing Expenses $1.24B $1.27B $1.15B $1.26B $1.30B
Selling General and Administrative Expenses $1.77B $1.79B $1.62B $1.79B $1.83B
Other Expenses $- $29.00M $84.00M $20.00M $7.00M
Operating Expenses $-2.01B $2.14B $2.10B $2.16B $2.19B
Cost and Expenses $3.69B $8.18B $7.43B $8.11B $8.05B
Interest Income $- $3.00M $17.00M $9.00M $13.00M
Interest Expense $-82.00M $110.00M $98.00M $111.00M $115.00M
Depreciation and Amortization $-582.00M $689.00M $740.00M $563.00M $509.00M
EBITDA $1.23B $1.71B $1.40B $1.52B $1.73B
EBITDA Ratio 14.71% 18.58% 17.30% 16.84% 18.70%
Operating Income $1.82B $1.02B $662.00M $954.00M $1.25B
Operating Income Ratio 21.64% 11.09% 8.17% 10.59% 13.43%
Total Other Income Expenses Net $-1.22B $-106.00M $-67.00M $-92.00M $-101.00M
Income Before Tax $599.00M $915.00M $595.00M $862.00M $1.14B
Income Before Tax Ratio 7.14% 9.94% 7.34% 9.57% 12.34%
Income Tax Expense $124.00M $168.00M $106.00M $152.00M $194.00M
Net Income $475.00M $747.00M $506.00M $758.00M $1.08B
Net Income Ratio 5.66% 8.12% 6.24% 8.41% 11.62%
EPS $2.74 $4.31 $2.91 $4.27 $6.11
EPS Diluted $2.74 $4.31 $2.89 $4.24 $6.11
Weighted Average Shares Outstanding 173.62M 172.65M 171.54M 175.73M 175.32M
Weighted Average Shares Outstanding Diluted 173.62M 173.40M 172.43M 176.82M 176.32M
SEC Filing Source Source Source Source Source


Breakdown December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020 December 31, 2019 September 30, 2019 June 30, 2019 March 31, 2019 December 31, 2018 September 30, 2018 June 30, 2018 March 31, 2018
Revenue $2.14B $2.14B $2.06B $2.06B $1.39B $2.36B $1.76B $1.76B $2.08B $1.96B $2.24B $2.29B $2.15B $2.29B $2.28B $2.29B $2.21B $2.27B $2.36B $2.44B
Cost of Revenue $1.51B $1.51B $1.34B $1.34B $615.00M $3.02B $1.13B $1.13B $- $- $- $- $- $- $- $- $- $- $- $-
Gross Profit $632.00M $632.00M $713.00M $713.00M $779.00M $-662.00M $632.50M $632.50M $2.08B $1.96B $2.24B $2.29B $2.15B $2.29B $2.28B $2.29B $2.21B $2.27B $2.36B $2.44B
Gross Profit Ratio 29.60% 29.60% 34.70% 34.70% 55.90% -28.10% 36.00% 36.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Research and Development Expenses $- $- $- $- $118.00M $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
General and Administrative Expenses $- $- $- $- $216.50M $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Selling and Marketing Expenses $- $- $- $- $537.00M $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Selling General and Administrative Expenses $- $- $- $- $754.50M $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Expenses $- $- $- $- $- $- $- $- $-2.00B $-1.77B $-1.85B $-2.09B $-1.98B $-2.02B $-2.03B $-2.02B $-2.01B $-2.02B $-1.97B $-2.02B
Operating Expenses $-489.50M $-489.50M $-512.00M $-512.00M $-1.76B $1.04B $-425.50M $-425.50M $-2.00B $-1.77B $-1.85B $-2.09B $-1.98B $-2.02B $-2.03B $-2.02B $-2.01B $-2.02B $-1.97B $-2.02B
Cost and Expenses $1.02B $1.02B $832.50M $832.50M $-1.15B $4.07B $700.50M $700.50M $-2.00B $-1.77B $-1.85B $-2.09B $-1.98B $-2.02B $-2.03B $-2.02B $-2.01B $-2.02B $-1.97B $-2.02B
Interest Income $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-29.00M $- $- $-25.00M $-18.00M
Interest Expense $-24.50M $-24.50M $-19.50M $-19.50M $-13.50M $-10.50M $-32.50M $-32.50M $- $- $- $- $- $- $- $- $- $- $- $-
Depreciation and Amortization $-148.75M $-148.00M $-148.00M $-148.00M $-187.00M $-138.00M $-135.00M $-135.00M $31.00M $52.75K $51.12K $47.30K $19.00M $44.65K $40.96K $40.37K $14.00M $- $1.97B $-
EBITDA $336.25M $335.50M $347.00M $347.00M $294.50M $346.50M $332.00M $332.00M $107.00M $192.00M $388.00M $207.00M $189.00M $266.00M $247.00M $271.00M $210.00M $249.00M $2.36B $411.00M
EBITDA Ratio 15.73% 15.70% 16.87% 16.87% 21.13% 14.69% 18.88% 18.88% 5.14% 9.79% 17.33% 9.03% 8.78% 11.62% 10.85% 11.82% 9.51% 10.99% 100.00% 16.88%
Operating Income $485.00M $483.50M $495.00M $495.00M $481.50M $208.50M $197.00M $197.00M $76.00M $192.00M $388.00M $207.00M $170.00M $266.00M $247.00M $271.00M $196.00M $249.00M $389.00M $411.00M
Operating Income Ratio 22.69% 22.62% 24.06% 24.06% 34.54% 8.84% 11.20% 11.20% 3.65% 9.79% 17.33% 9.03% 7.90% 11.62% 10.85% 11.82% 8.88% 10.99% 16.49% 16.88%
Total Other Income Expenses Net $-367.00M $-365.50M $-313.50M $-313.50M $-250.00M $164.00M $-22.50M $-22.50M $-15.00M $-21.00M $-178.00M $-13.00M $-11.00M $-24.00M $-28.00M $-29.00M $-26.00M $-32.00M $-25.00M $-18.00M
Income Before Tax $118.00M $118.00M $181.50M $181.50M $231.50M $372.50M $174.50M $174.50M $61.00M $171.00M $210.00M $194.00M $159.00M $242.00M $219.00M $242.00M $170.00M $217.00M $364.00M $393.00M
Income Before Tax Ratio 5.52% 5.52% 8.82% 8.82% 16.61% 15.80% 9.92% 9.92% 2.93% 8.72% 9.38% 8.46% 7.39% 10.57% 9.62% 10.56% 7.70% 9.58% 15.43% 16.14%
Income Tax Expense $26.00M $26.00M $36.00M $36.00M $20.00M $39.00M $32.00M $32.00M $17.00M $33.00M $37.00M $30.00M $30.00M $42.00M $36.00M $44.00M $23.00M $40.00M $64.00M $67.00M
Net Income $92.00M $92.00M $145.50M $145.50M $211.50M $331.50M $139.50M $139.50M $99.00M $167.00M $101.00M $167.00M $123.00M $236.00M $204.00M $195.00M $258.00M $188.00M $301.00M $330.00M
Net Income Ratio 4.30% 4.30% 7.07% 7.07% 15.17% 14.06% 7.93% 7.93% 4.76% 8.52% 4.51% 7.28% 5.72% 10.31% 8.96% 8.51% 11.68% 8.30% 12.76% 13.55%
EPS $0.53 $0.53 $0.84 $0.84 $1.22 $1.91 $0.81 $0.81 $0.00 $0.96 $0.58 $0.96 $0.00 $1.20 $1.14 $1.10 $0.00 $1.06 $1.70 $1.88
EPS Diluted $0.53 $0.53 $0.84 $0.84 $1.22 $1.91 $0.81 $0.81 $0.00 $0.96 $0.58 $0.96 $0.00 $1.20 $1.14 $1.10 $0.00 $1.06 $1.70 $1.88
Weighted Average Shares Outstanding 173.42M 173.42M 173.36M 173.36M 173.18M 173.89M 173.10M 173.10M - 171.80M 170.80M 171.40M - 176.20M 176.50M 176.10M - 175.70M 175.20M 174.80M
Weighted Average Shares Outstanding Diluted 173.42M 173.42M 173.36M 173.36M 173.18M 173.89M 173.10M 173.10M - 171.80M 170.80M 171.40M - 176.20M 176.50M 176.10M - 175.70M 175.20M 174.80M
SEC Filing Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source

Annual Balance Sheet

Breakdown December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019 December 31, 2018
Cash and Cash Equivalents $2.75B $1.56B $871.00M $800.00M $1.28B
Short Term Investments $125.00M $489.00M $43.00M $688.00M $1.28B
Cash and Short Term Investments $2.88B $2.05B $914.00M $1.49B $2.56B
Net Receivables $- $- $- $- $1.57M
Inventory $2.34B $2.30B $1.88B $2.02B $1.99B
Other Current Assets $- $- $- $- $1.76B
Total Current Assets $8.13B $6.13B $5.42B $5.22B $6.31B
Property Plant Equipment Net $3.58B $3.96B $3.77B $4.04B $3.51B
Goodwill $2.98B $2.95B $2.52B $2.28B $1.91B
Intangible Assets $2.16B $2.36B $1.94B $1.23B $1.18B
Goodwill and Intangible Assets $5.15B $5.31B $4.46B $3.52B $3.09B
Long Term Investments $196.00M $-230.00M $278.00M $-376.00M $-899.00M
Tax Assets $- $203.00M $239.00M $217.00M $248.00M
Other Non-Current Assets $-8.92B $644.00M $193.00M $823.00M $1.38B
Total Non-Current Assets $8.92B $9.88B $8.94B $8.22B $7.33B
Other Assets $356.00M $- $- $- $-
Total Assets $- $16.01B $14.36B $13.44B $13.64B
Account Payables $1.41B $1.57B $1.22B $1.34B $1.43B
Short Term Debt $- $104.00M $107.00M $189.00M $380.00M
Tax Payables $- $137.00M $102.00M $88.00M $158.00M
Deferred Revenue $- $746.00M $862.00M $604.00M $158.00M
Other Current Liabilities $1.17B $-127.00M $-25.00M $-63.00M $445.00M
Total Current Liabilities $2.58B $2.43B $2.26B $2.16B $2.57B
Long Term Debt $2.84B $2.99B $3.48B $2.46B $2.27B
Deferred Revenue Non-Current $- $62.00M $76.00M $65.00M $39.00M
Deferred Tax Liabilities Non-Current $- $485.00M $433.00M $296.00M $254.00M
Other Non-Current Liabilities $- $649.00M $625.00M $620.00M $690.00M
Total Non-Current Liabilities $2.84B $4.18B $4.61B $3.44B $3.25B
Other Liabilities $1.14B $- $- $- $-
Total Liabilities $6.56B $6.62B $6.88B $5.61B $5.83B
Preferred Stock $- $- $- $- $-
Common Stock $328.00M $328.00M $338.00M $338.00M $338.00M
Retained Earnings $9.78B $8.54B $7.79B $7.71B $7.38B
Accumulated Other Comprehensive Income Loss $- $- $- $- $-
Other Total Stockholders Equity $-10.11B $450.00M $-730.00M $-320.00M $63.00M
Total Stockholders Equity $10.11B $9.32B $7.40B $7.73B $7.78B
Total Equity $10.11B $9.40B $7.49B $7.83B $7.82B
Total Liabilities and Stockholders Equity $- $16.01B $14.36B $13.44B $13.64B
Minority Interest $- $79.00M $88.00M $104.00M $33.00M
Total Liabilities and Total Equity $- $16.01B $14.36B $13.44B $13.64B
Total Investments $321.00M $259.00M $321.00M $312.00M $378.00M
Total Debt $- $3.09B $3.59B $2.65B $2.65B
Net Debt $-2.75B $1.53B $2.71B $1.85B $1.37B


Balance Sheet Charts

Breakdown December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020 December 31, 2019 September 30, 2019 June 30, 2019 March 31, 2019 December 31, 2018 September 30, 2018 June 30, 2018 March 31, 2018
Cash and Cash Equivalents $2.75B $2.75B $792.00M $792.00M $1.56B $1.56B $1.64B $1.64B $871.00M $1.69B $1.30B $1.40B $800.00M $926.00M $1.14B $1.04B $1.28B $997.00M $813.00M $1.09B
Short Term Investments $125.00M $125.00M $838.00M $838.00M $489.00M $489.00M $215.00M $215.00M $43.00M $40.00M $655.00M $195.00M $688.00M $853.00M $1.15B $1.43B $1.28B $1.00B $1.01B $954.00M
Cash and Short Term Investments $2.88B $2.88B $1.63B $1.63B $2.05B $2.05B $1.85B $1.85B $914.00M $1.73B $1.96B $1.59B $1.49B $1.78B $2.29B $2.47B $2.56B $2.00B $1.82B $2.04B
Net Receivables $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Inventory $2.34B $2.34B $2.39B $2.39B $2.30B $2.30B $2.10B $2.10B $1.88B $1.95B $2.18B $2.14B $2.02B $2.12B $2.07B $2.06B $1.99B $2.00B $2.02B $1.93B
Other Current Assets $- $- $3.56B $- $1.78B $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Current Assets $8.13B $8.13B $7.58B $7.58B $6.13B $6.13B $5.81B $5.81B $5.42B $6.30B $5.89B $5.64B $5.22B $5.79B $6.27B $6.55B $6.31B $6.04B $5.98B $5.96B
Property Plant Equipment Net $3.58B $3.58B $3.57B $3.57B $3.96B $3.96B $3.75B $3.75B $3.77B $3.65B $4.04B $4.01B $4.04B $3.93B $3.76B $3.80B $3.51B $3.38B $3.35B $3.25B
Goodwill $2.98B $2.98B $- $- $2.95B $2.93B $- $- $2.52B $- $- $- $2.28B $- $- $- $1.91B $- $- $-
Intangible Assets $2.16B $2.16B $- $5.19B $2.36B $2.38B $- $4.69B $1.94B $- $- $- $1.23B $- $- $- $1.18B $- $- $-
Goodwill and Intangible Assets $5.15B $5.15B $5.19B $5.19B $5.31B $5.31B $4.69B $4.69B $4.46B $3.69B $4.20B $3.49B $3.52B $3.43B $3.23B $3.26B $3.09B $3.08B $3.04B $2.98B
Long Term Investments $196.00M $196.00M $-572.00M $266.00M $-230.00M $259.00M $266.00M $69.00M $278.00M $312.00M $-234.00M $214.00M $-376.00M $-398.00M $-738.00M $-1.00B $-899.00M $-388.00M $-413.00M $-228.00M
Tax Assets $- $- $133.00M $- $203.00M $- $224.00M $- $239.00M $226.00M $231.00M $225.00M $217.00M $192.00M $215.00M $233.00M $248.00M $245.00M $287.00M $292.00M
Other Non-Current Assets $-8.92B $-8.92B $951.00M $-9.03B $644.00M $-9.53B $700.00M $-8.51B $386.00M $192.00M $1.42B $474.00M $1.65B $1.73B $2.32B $2.89B $2.76B $2.04B $1.02B $1.95B
Total Non-Current Assets $8.92B $8.92B $9.27B $9.03B $9.88B $9.53B $9.28B $8.51B $8.94B $7.97B $8.94B $8.18B $8.22B $8.02B $7.63B $7.74B $7.33B $7.34B $7.29B $7.26B
Other Assets $356.00M $356.00M $- $246.00M $- $358.00M $- $771.00M $- $- $- $- $- $- $- $- $- $- $- $-
Total Assets $- $- $16.85B $- $16.01B $- $15.10B $- $14.36B $14.27B $14.83B $13.81B $13.44B $13.81B $13.90B $14.29B $13.64B $13.38B $13.28B $13.23B
Account Payables $1.41B $1.41B $1.54B $1.54B $1.57B $1.56B $1.45B $1.45B $1.22B $1.18B $1.47B $1.55B $1.34B $1.36B $1.45B $1.47B $1.43B $1.39B $1.48B $1.65B
Short Term Debt $- $- $98.00M $- $104.00M $- $135.00M $- $107.00M $316.00M $605.00M $450.00M $189.00M $126.00M $438.00M $429.00M $380.00M $110.00M $86.00M $88.00M
Tax Payables $- $- $97.00M $- $137.00M $- $93.00M $- $102.00M $83.00M $66.00M $43.00M $88.00M $91.00M $88.00M $99.00M $158.00M $130.00M $135.00M $108.00M
Deferred Revenue $- $- $- $- $- $- $195.00M $- $862.00M $450.00M $203.00M $215.00M $604.00M $250.00M $221.00M $237.00M $723.00M $236.00M $248.00M $234.00M
Other Current Liabilities $1.17B $1.17B $1.28B $1.48B $619.00M $869.00M $458.00M $881.00M $-25.00M $319.00M $499.00M $436.00M $-63.00M $375.00M $496.00M $440.00M $-120.00M $377.00M $428.00M $415.00M
Total Current Liabilities $2.58B $2.58B $3.02B $3.02B $2.43B $2.43B $2.33B $2.33B $2.26B $2.35B $2.85B $2.70B $2.16B $2.21B $2.69B $2.68B $2.57B $2.25B $2.38B $2.49B
Long Term Debt $2.84B $2.84B $2.98B $2.98B $2.99B $2.84B $2.56B $2.99B $3.48B $2.90B $2.91B $1.92B $2.46B $1.89B $1.86B $1.90B $2.27B $2.10B $2.09B $2.04B
Deferred Revenue Non-Current $- $- $- $- $62.00M $- $428.00M $- $76.00M $554.00M $582.00M $546.00M $65.00M $571.00M $570.00M $535.00M $39.00M $472.00M $482.00M $507.00M
Deferred Tax Liabilities Non-Current $- $- $491.00M $- $485.00M $- $499.00M $- $433.00M $351.00M $360.00M $283.00M $296.00M $270.00M $248.00M $241.00M $254.00M $279.00M $283.00M $254.00M
Other Non-Current Liabilities $- $- $534.00M $- $649.00M $- $255.00M $- $625.00M $158.00M $166.00M $154.00M $620.00M $143.00M $116.00M $178.00M $690.00M $193.00M $159.00M $175.00M
Total Non-Current Liabilities $2.84B $2.84B $4.01B $2.98B $4.18B $2.84B $4.17B $2.99B $4.61B $4.51B $4.60B $3.45B $3.44B $3.44B $3.37B $3.39B $3.25B $3.51B $3.49B $3.49B
Other Liabilities $1.14B $1.14B $- $1.02B $- $1.35B $- $1.18B $- $- $- $- $- $- $- $- $- $- $- $-
Total Liabilities $6.56B $6.56B $7.03B $7.03B $6.62B $6.62B $6.50B $6.50B $6.88B $6.86B $7.45B $6.15B $5.61B $5.65B $6.06B $6.06B $5.83B $5.76B $5.87B $5.98B
Preferred Stock $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Common Stock $328.00M $328.00M $328.00M $328.00M $328.00M $328.00M $- $8.52B $338.00M $- $- $- $338.00M $- $- $- $338.00M $- $- $-
Retained Earnings $9.78B $9.78B $8.55B $8.55B $8.54B $8.54B $- $- $7.79B $- $- $- $7.71B $- $- $- $7.38B $- $- $-
Accumulated Other Comprehensive Income Loss $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Total Stockholders Equity $-10.11B $-10.11B $851.00M $-8.88B $450.00M $-8.87B $- $-8.52B $-730.00M $- $- $- $-320.00M $- $- $- $63.00M $- $- $-
Total Stockholders Equity $10.11B $10.11B $9.73B $8.88B $9.32B $8.87B $8.52B $8.52B $7.40B $7.32B $7.28B $7.56B $7.73B $8.06B $7.79B $8.17B $7.78B $7.59B $7.37B $7.21B
Total Equity $10.11B $10.11B $9.82B $8.88B $9.40B $- $8.60B $- $7.49B $7.41B $7.38B $7.66B $7.83B $8.16B $7.84B $8.23B $7.82B $7.62B $7.40B $7.25B
Total Liabilities and Stockholders Equity $- $- $16.85B $- $16.01B $- $15.10B $- $14.36B $14.27B $14.83B $13.81B $13.44B $13.81B $13.90B $14.29B $13.64B $13.38B $13.28B $13.23B
Minority Interest $- $- $92.00M $- $79.00M $- $79.00M $- $88.00M $91.00M $101.00M $103.00M $104.00M $99.00M $54.00M $57.00M $33.00M $35.00M $36.00M $36.00M
Total Liabilities and Total Equity $- $- $16.85B $- $16.01B $- $15.10B $- $14.36B $14.27B $14.83B $13.81B $13.44B $13.81B $13.90B $14.29B $13.64B $13.38B $13.28B $13.23B
Total Investments $321.00M $321.00M $266.00M $1.10B $259.00M $748.00M $481.00M $284.00M $321.00M $352.00M $421.00M $409.00M $312.00M $455.00M $411.00M $428.00M $378.00M $613.00M $593.00M $726.00M
Total Debt $- $- $3.08B $- $3.09B $- $3.12B $- $3.59B $3.77B $4.10B $2.92B $2.65B $2.58B $2.87B $2.86B $2.65B $2.68B $2.65B $2.64B
Net Debt $-2.75B $-2.75B $2.29B $-792.00M $1.53B $-1.56B $1.48B $-1.64B $2.71B $2.08B $2.80B $1.52B $1.85B $1.66B $1.73B $1.82B $1.37B $1.68B $1.84B $1.55B

Annual Cash Flow

Breakdown December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019 December 31, 2018
Net Income $1.70B $1.68B $508.00M $764.00M $1.08B
Depreciation and Amortization $632.00M $681.00M $740.00M $632.00M $509.00M
Deferred Income Tax $- $-920.00M $47.00M $-93.00M $-60.00M
Stock Based Compensation $35.00M $22.00M $29.00M $34.00M $25.00M
Change in Working Capital $-575.00M $-164.00M $35.00M $13.00M $-279.00M
Accounts Receivables $-133.00M $- $- $- $-
Inventory $-442.00M $-323.00M $-36.00M $114.00M $-166.00M
Accounts Payables $- $- $- $- $-
Other Working Capital $- $159.00M $71.00M $-101.00M $-113.00M
Other Non Cash Items $-827.00M $128.00M $135.00M $35.00M $117.00M
Net Cash Provided by Operating Activities $965.00M $1.43B $1.49B $1.39B $1.39B
Investments in Property Plant and Equipment $-506.00M $-577.00M $-626.00M $-641.00M $-693.00M
Acquisitions Net $- $1.09B $-1.53B $-519.00M $294.00M
Purchases of Investments $- $-2.11B $-488.00M $-1.25B $-1.62B
Sales Maturities of Investments $- $1.75B $1.16B $1.78B $1.22B
Other Investing Activities $1.38B $63.00M $6.00M $99.00M $192.00M
Net Cash Used for Investing Activities $876.00M $208.00M $-1.48B $-525.00M $-605.00M
Debt Repayment $- $- $- $- $-
Common Stock Issued $- $34.00M $63.00M $180.00M $97.00M
Common Stock Repurchased $-210.00M $-165.00M $-309.00M $-869.00M $-236.00M
Dividends Paid $-345.00M $-266.00M $-289.00M $-291.00M $-225.00M
Other Financing Activities $-300.00M $-718.00M $372.00M $-1.04B $-176.00M
Net Cash Used Provided by Financing Activities $-645.00M $-984.00M $83.00M $-1.33B $-401.00M
Effect of Forex Changes on Cash $-2.00M $39.00M $-24.00M $-9.00M $-3.00M
Net Change in Cash $1.19B $690.00M $71.00M $-481.00M $382.00M
Cash at End of Period $2.75B $1.56B $871.00M $800.00M $1.28B
Cash at Beginning of Period $1.56B $871.00M $800.00M $1.28B $899.00M
Operating Cash Flow $965.00M $1.43B $1.49B $1.39B $1.39B
Capital Expenditure $-506.00M $-577.00M $-626.00M $-641.00M $-693.00M
Free Cash Flow $459.00M $850.00M $868.00M $744.00M $698.00M

Cash Flow Charts

Breakdown December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020 December 31, 2019 September 30, 2019 June 30, 2019 March 31, 2019 December 31, 2018 September 30, 2018 June 30, 2018 March 31, 2018
Net Income $625.00M $625.00M $225.00M $225.00M $334.00M $334.00M $504.00M $504.00M $-608.00M $370.00M $388.00M $358.00M $-475.00M $416.00M $407.00M $416.00M $-335.00M $385.00M $503.00M $526.00M
Depreciation and Amortization $-148.00M $-148.00M $148.00M $148.00M $212.50M $163.50M $135.00M $135.00M $- $- $- $- $- $- $- $- $- $- $- $-
Deferred Income Tax $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Stock Based Compensation $- $- $- $- $11.00M $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Change in Working Capital $- $- $- $- $-161.50M $- $- $- $187.00M $34.00M $-86.00M $-100.00M $220.00M $32.00M $-74.00M $-165.00M $- $- $-271.00M $-233.00M
Accounts Receivables $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Inventory $- $- $- $- $-161.50M $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Accounts Payables $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Working Capital $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Non Cash Items $-144.00M $-144.00M $-223.50M $-223.50M $28.00M $-73.50M $-349.50M $-349.50M $925.00M $2.00M $-5.00M $29.00M $699.00M $-14.00M $-27.00M $-50.00M $793.00M $45.00M $-39.00M $17.00M
Net Cash Provided by Operating Activities $333.00M $333.00M $149.50M $149.50M $424.00M $424.00M $289.50M $289.50M $504.00M $406.00M $297.00M $287.00M $444.00M $434.00M $306.00M $201.00M $458.00M $430.00M $193.00M $310.00M
Investments in Property Plant and Equipment $-172.50M $-172.50M $-149.50M $-149.50M $-98.50M $-98.50M $-118.00M $-118.00M $-214.00M $-128.00M $-128.00M $-156.00M $-213.00M $-155.00M $-121.00M $-152.00M $-205.00M $-152.00M $-161.00M $-175.00M
Acquisitions Net $- $- $- $- $- $- $- $- $-1.53B $-2.00M $4.00M $-3.00M $-535.00M $14.00M $- $2.00M $- $- $4.00M $26.00M
Purchases of Investments $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-1.57B $6.00M $- $-
Sales Maturities of Investments $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Investing Activities $948.00M $948.00M $-173.50M $-173.50M $-292.00M $-292.00M $612.50M $612.50M $538.00M $504.00M $-1.32B $329.00M $374.00M $-47.00M $143.00M $-476.00M $1.48B $-147.00M $-225.00M $-169.00M
Net Cash Used for Investing Activities $775.50M $775.50M $-323.00M $-323.00M $-390.50M $-390.50M $494.50M $494.50M $-996.00M $502.00M $-1.31B $326.00M $-161.00M $-33.00M $143.00M $-474.00M $-100.00M $-141.00M $-221.00M $-143.00M
Debt Repayment $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Common Stock Issued $- $- $- $- $- $- $- $- $15.00M $15.00M $17.00M $16.00M $16.00M $28.00M $81.00M $55.00M $6.00M $33.00M $41.00M $17.00M
Common Stock Repurchased $- $- $-105.00M $-105.00M $-22.50M $-22.50M $-60.00M $-60.00M $- $-26.00M $- $-283.00M $-421.00M $-199.00M $-249.00M $- $-23.00M $-76.00M $-125.00M $-12.00M
Dividends Paid $-173.00M $- $-86.00M $-86.00M $-77.00M $- $-94.50M $-94.50M $- $-126.00M $- $- $-14.00M $-119.00M $- $- $- $- $- $-
Other Financing Activities $54.50M $-118.50M $-132.50M $-132.50M $-20.00M $-97.00M $-300.50M $-300.50M $-320.00M $-391.00M $932.00M $-12.00M $-377.00M $-505.00M $-353.00M $36.00M $-65.00M $-126.00M $-224.00M $14.00M
Net Cash Used Provided by Financing Activities $-118.50M $-118.50M $-218.50M $-218.50M $-97.00M $-97.00M $-395.00M $-395.00M $-320.00M $-517.00M $932.00M $-12.00M $-391.00M $-624.00M $-353.00M $36.00M $-65.00M $-126.00M $-224.00M $14.00M
Effect of Forex Changes on Cash $-8.50M $-8.50M $7.50M $7.50M $24.00M $24.00M $-4.50M $-4.50M $-3.00M $-5.00M $-11.00M $-5.00M $-18.00M $12.00M $-2.00M $-1.00M $-9.00M $21.00M $-21.00M $6.00M
Net Change in Cash $981.50M $981.50M $-384.50M $-384.50M $-39.50M $-39.50M $384.50M $384.50M $-815.00M $-269.00M $559.00M $596.00M $-126.00M $-1.36B $-187.00M $1.19B $284.00M $-822.00M $-221.00M $1.14B
Cash at End of Period $981.50M $981.50M $-384.50M $-384.50M $-39.50M $1.60B $1.64B $384.50M $871.00M $1.69B $1.96B $1.40B $800.00M $926.00M $2.29B $2.47B $1.28B $997.00M $1.82B $2.04B
Cash at Beginning of Period $- $- $- $- $- $1.64B $1.26B $- $1.69B $1.96B $1.40B $800.00M $926.00M $2.29B $2.47B $1.28B $997.00M $1.82B $2.04B $899.00M
Operating Cash Flow $333.00M $333.00M $149.50M $149.50M $424.00M $424.00M $289.50M $289.50M $504.00M $406.00M $297.00M $287.00M $444.00M $434.00M $306.00M $201.00M $458.00M $430.00M $193.00M $310.00M
Capital Expenditure $-172.50M $-172.50M $-149.50M $-149.50M $-98.50M $-98.50M $-118.00M $-118.00M $-214.00M $-128.00M $-128.00M $-156.00M $-213.00M $-155.00M $-121.00M $-152.00M $-205.00M $-152.00M $-161.00M $-175.00M
Free Cash Flow $160.50M $160.50M $- $- $325.50M $325.50M $171.50M $171.50M $290.00M $278.00M $169.00M $131.00M $231.00M $279.00M $185.00M $49.00M $253.00M $278.00M $32.00M $135.00M

Koninklijke DSM N.V Dividends

Explore Koninklijke DSM N.V's dividend history, including dividend yield, payout ratio, and historical payments.

Dividend Yield

1.74%

Dividend Payout Ratio

72.63%

Dividend Paid & Capex Coverage Ratio

1.13x

Koninklijke DSM N.V Dividend History

Dividend Adjusted Dividend Date Record Date Payment Date Declaration Date
$0.93 $0.93 August 04, 2022
$1.7 $1.7 May 12, 2022
$0.8 $0.8 August 05, 2021
$1.6 $1.6 May 10, 2021
$0.8 $0.8 August 06, 2020 August 07, 2020 August 28, 2020 August 05, 2020
$1.63 $1.63 May 12, 2020 May 13, 2020 June 03, 2020 May 08, 2020
$0.77 $0.77 August 05, 2019 August 06, 2019 August 26, 2019 August 01, 2019
$1.53 $1.53 May 10, 2019 May 13, 2019 June 03, 2019 February 15, 2019
$0.77 $0.77 August 03, 2018 August 06, 2018 August 24, 2018 August 01, 2018
$1.27 $1.27 May 11, 2018 May 14, 2018 June 01, 2018 February 15, 2018
$1.2 $1.2 May 05, 2017 May 08, 2017 May 26, 2017 February 15, 2017
$0.55 $0.55 August 04, 2016 August 05, 2016 August 25, 2016 August 02, 2016
$1.1 $1.1 May 03, 2016 May 04, 2016 May 24, 2016 February 17, 2016
$0.55 $0.55 August 05, 2015 August 06, 2015 August 25, 2015 August 04, 2015
$1.1 $1.1 May 05, 2015 May 06, 2015 May 27, 2015 February 11, 2015
$0.55 $0.55 August 06, 2014 August 08, 2014 August 27, 2014 August 05, 2014
$1.15 $1.15 May 09, 2014 May 13, 2014 June 03, 2014 February 26, 2014
$0.5 $0.5 August 07, 2013 August 09, 2013 August 29, 2013 August 06, 2013
$1.02 $1.02 May 07, 2013 May 09, 2013 May 29, 2013 February 20, 2013
$0.48 $0.48 August 08, 2012 August 10, 2012 August 30, 2012 August 07, 2012

Koninklijke DSM N.V News

Read the latest news about Koninklijke DSM N.V, including recent articles, headlines, and updates.

Similar Companies

A
Akzo Nobel N.V.

AKZA.AS

Price: $59.46

Market Cap: $10.15B

K
Koninklijke KPN N.V.

KPN.AS

Price: $3.78

Market Cap: $14.70B

P
Koninklijke Philips N.V.

PHIA.AS

Price: $23.62

Market Cap: $21.85B

R
Randstad N.V.

RAND.AS

Price: $40.15

Market Cap: $7.03B

W
Wolters Kluwer N.V.

WKL.AS

Price: $143.00

Market Cap: $33.51B

Related Metrics

Explore detailed financial metrics and analysis for DSM.AS.